SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

MusclePharm Corp – ‘10-Q/A’ for 6/30/14 – ‘EX-101.SCH’

On:  Friday, 10/31/14, at 4:31pm ET   ·   For:  6/30/14   ·   Accession #:  1144204-14-64325   ·   File #:  0-53166

Previous ‘10-Q’:  ‘10-Q’ on 8/5/14 for 6/30/14   ·   Next:  ‘10-Q’ on 11/14/14 for 9/30/14   ·   Latest:  ‘10-Q’ on 5/16/22 for 3/31/22

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/31/14  MusclePharm Corp                  10-Q/A      6/30/14   92:9M                                     Toppan Merrill/FA

Amendment to Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q/A      Amendment to Quarterly Report                       HTML    356K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     31K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     31K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     26K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     26K 
62: R1          Document And Entity Information                     HTML     49K 
49: R2          Consolidated Balance Sheets                         HTML    137K 
60: R3          Consolidated Balance Sheets [Parenthetical]         HTML     49K 
64: R4          Consolidated Statements of Operations               HTML    111K 
84: R5          Consolidated Statements of Cash Flows               HTML    157K 
51: R6          Nature of Operations and Basis of Presentation      HTML     32K 
59: R7          Summary of Significant Accounting Policies          HTML     70K 
44: R8          Composition of Certain Financial Statement          HTML    154K 
                Captions                                                         
34: R9          Concentrations                                      HTML     68K 
85: R10         Financial Instruments                               HTML     46K 
66: R11         Debt                                                HTML     54K 
65: R12         Derivative Liabilities                              HTML     35K 
71: R13         Restricted Stock Units                              HTML     36K 
72: R14         Stockholders' Equity                                HTML    114K 
69: R15         Commitments, Contingencies and Other Matters        HTML     71K 
73: R16         Defined Contribution Plan                           HTML     30K 
61: R17         Related Party Transactions                          HTML     35K 
63: R18         Endorsement Agreement                               HTML     29K 
68: R19         Biozone Acquisition                                 HTML    122K 
92: R20         Intangible Assets                                   HTML     66K 
80: R21         Restatement of June 30, 2014 Unaudited              HTML    118K 
                Consolidated Financial Statements                                
55: R22         Subsequent Events                                   HTML     31K 
67: R23         Summary of Significant Accounting Policies          HTML    139K 
                (Policies)                                                       
57: R24         Concentrations (Tables)                             HTML     68K 
25: R25         Composition of Certain Financial Statement          HTML    164K 
                Captions (Tables)                                                
81: R26         Financial Instruments (Tables)                      HTML     40K 
88: R27         Debt (Tables)                                       HTML     51K 
39: R28         Derivative Liabilities (Tables)                     HTML     32K 
38: R29         Stockholders' Equity (Tables)                       HTML    108K 
42: R30         Committments, Contingencies and Other Matters       HTML     65K 
                (Tables)                                                         
43: R31         Biozone Acquisition (Tables)                        HTML    116K 
45: R32         Intangible Assets (Tables)                          HTML     67K 
19: R33         Restatement of June 30, 2014 Unaudited              HTML    113K 
                Consolidated Financial Statements (Tables)                       
78: R34         Composition of Certain Financial Statement          HTML     35K 
                Captions (Details)                                               
53: R35         Composition of Certain Financial Statement          HTML     39K 
                Captions (Details 1)                                             
56: R36         Composition of Certain Financial Statement          HTML     55K 
                Captions (Details 2)                                             
29: R37         Composition of Certain Financial Statement          HTML     33K 
                Captions (Details 3)                                             
91: R38         Composition of Certain Financial Statement          HTML     32K 
                Captions (Details 5)                                             
12: R39         Composition of Certain Financial Statement          HTML     51K 
                Captions (Details 4)                                             
46: R40         Composition of Certain Financial Statement          HTML     47K 
                Captions (Details 6)                                             
83: R41         Composition of Certain Financial Statement          HTML     34K 
                Captions (Details 7)                                             
27: R42         Composition of Certain Financial Statement          HTML     35K 
                Captions (Details 8)                                             
37: R43         Composition of Certain Financial Statement          HTML     28K 
                Captions (Details Textual)                                       
41: R44         Concentrations (Details)                            HTML     33K 
50: R45         Concentrations (Details 1)                          HTML     33K 
18: R46         Concentrations (Details 2)                          HTML     30K 
33: R47         Financial Instruments (Details)                     HTML     41K 
14: R48         Financial Instruments (Details Textual)             HTML     26K 
82: R49         Debt (Details)                                      HTML     44K 
26: R50         Debt (Details 1)                                    HTML     30K 
79: R51         Debt (Details 2)                                    HTML     30K 
30: R52         Debt (Details Textual)                              HTML     47K 
47: R53         Derivative Liabilities (Details)                    HTML     34K 
13: R54         Derivative Liabilities (Details Textual)            HTML     30K 
17: R55         Restricted Stock Units (Details Textual)            HTML     71K 
40: R56         Stockholders' Equity (Details)                      HTML     55K 
21: R57         Stockholders' Equity (Details 1)                    HTML     30K 
86: R58         Stockholders' Equity (Details 2)                    HTML     48K 
52: R59         Stockholders' Equity (Details 3)                    HTML     53K 
70: R60         Stockholders' Equity (Details Textual)              HTML     41K 
32: R61         Commitments, Contingencies and Other Matters        HTML     45K 
                (Details)                                                        
35: R62         Commitments, Contingencies and Other Matters        HTML     41K 
                (Details 1)                                                      
77: R63         Commitments, Contingencies and Other Matters        HTML     40K 
                (Details 2)                                                      
75: R64         Commitments, Contingencies and Other Matters        HTML     53K 
                (Details Textual)                                                
54: R65         Defined Contribution Plan (Details Textual)         HTML     29K 
76: R66         Related Party Transactions (Details Textual)        HTML     51K 
31: R67         Endorsement Agreement (Details Textual)             HTML     28K 
58: R68         Biozone Acquisition (Details)                       HTML     63K 
87: R69         Biozone Acquisition (Details 1)                     HTML     32K 
16: R70         Biozone Acquisition (Details 2)                     HTML     42K 
24: R71         Biozone Acquisition (Details Textual)               HTML     36K 
48: R72         Intangible Assets (Details)                         HTML     43K 
20: R73         Intangible Assets (Details 1)                       HTML     41K 
90: R74         Intangible Assets (Details Textual)                 HTML     28K 
28: R75         Restatement of June 30, 2014 Unaudited              HTML    113K 
                Consolidated Financial Statements (Details)                      
22: R76         Restatement of June 30, 2014 Unaudited              HTML     32K 
                Consolidated Financial Statements (Details                       
                Textual)                                                         
23: R77         Subsequent Events (Details Textual)                 HTML     39K 
89: XML         IDEA XML File -- Filing Summary                      XML    136K 
15: EXCEL       IDEA Workbook of Financial Reports                  XLSX    190K 
36: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS   1.52M 
 6: EX-101.INS  XBRL Instance -- mslp-20140630                       XML   2.06M 
 8: EX-101.CAL  XBRL Calculations -- mslp-20140630_cal               XML    220K 
 9: EX-101.DEF  XBRL Definitions -- mslp-20140630_def                XML   1.09M 
10: EX-101.LAB  XBRL Labels -- mslp-20140630_lab                     XML   1.27M 
11: EX-101.PRE  XBRL Presentations -- mslp-20140630_pre              XML   1.22M 
 7: EX-101.SCH  XBRL Schema -- mslp-20140630                         XSD    230K 
74: ZIP         XBRL Zipped Folder -- 0001144204-14-064325-xbrl      Zip    191K

‘EX-101.SCH’   —   XBRL Schema — mslp-20140630

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- Generated by DataTracks version 1.1.7 on 31-Oct-2014 [02:20:04] {PM} EST - www.datatracks.com -->
<schema targetNamespace="http://www.musclepharm.com/20140630" elementFormDefault="qualified" xmlns:mslp="http://www.musclepharm.com/20140630" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-gaap="http://fasb.org/us-gaap/2014-01-31" xmlns:country="http://xbrl.sec.gov/country/2013-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2014-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2014-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:us-types="http://fasb.org/us-types/2014-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric">
<annotation>
<appinfo>
<link:roleType roleURI="http://www.musclepharm.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
<link:definition> 101 - Document - Document And Entity Information </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/ConsolidatedBalanceSheets" id="ConsolidatedBalanceSheets">
<link:definition> 102 - Statement - Consolidated Balance Sheets </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/ConsolidatedBalanceSheetsParenthetical" id="ConsolidatedBalanceSheetsParenthetical">
<link:definition> 103 - Statement - Consolidated Balance Sheets [Parenthetical] </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/ConsolidatedStatementsOfOperations" id="ConsolidatedStatementsOfOperations">
<link:definition> 104 - Statement - Consolidated Statements of Operations </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/ConsolidatedStatementsOfCashFlows" id="ConsolidatedStatementsOfCashFlows">
<link:definition> 105 - Statement - Consolidated Statements of Cash Flows </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/NatureOfOperationsAndBasisOfPresentation" id="NatureOfOperationsAndBasisOfPresentation">
<link:definition> 106 - Disclosure - Nature of Operations and Basis of Presentation </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
<link:definition> 107 - Disclosure - Summary of Significant Accounting Policies </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/CompositionOfCertainFinancialStatementCaptions" id="CompositionOfCertainFinancialStatementCaptions">
<link:definition> 108 - Disclosure - Composition of Certain Financial Statement Captions </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/Concentrations" id="Concentrations">
<link:definition> 109 - Disclosure - Concentrations </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/FinancialInstruments" id="FinancialInstruments">
<link:definition> 110 - Disclosure - Financial Instruments </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/Debt" id="Debt">
<link:definition> 111 - Disclosure - Debt </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/DerivativeLiabilities" id="DerivativeLiabilities">
<link:definition> 112 - Disclosure - Derivative Liabilities </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/RestrictedStockUnits" id="RestrictedStockUnits">
<link:definition> 113 - Disclosure - Restricted Stock Units </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/StockholdersEquity" id="StockholdersEquity">
<link:definition> 114 - Disclosure - Stockholders' Equity </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/CommitmentsContingenciesAndOtherMatters" id="CommitmentsContingenciesAndOtherMatters">
<link:definition> 115 - Disclosure - Commitments, Contingencies and Other Matters </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/DefinedContributionPlan" id="DefinedContributionPlan">
<link:definition> 116 - Disclosure - Defined Contribution Plan </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
<link:definition> 117 - Disclosure - Related Party Transactions </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/EndorsementAgreement" id="EndorsementAgreement">
<link:definition> 118 - Disclosure - Endorsement Agreement </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/BiozoneAcquisition" id="BiozoneAcquisition">
<link:definition> 119 - Disclosure - Biozone Acquisition </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/IntangibleAssets" id="IntangibleAssets">
<link:definition> 120 - Disclosure - Intangible Assets </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/RestatementOfJune302014UnauditedConsolidatedFinancialStatements" id="RestatementOfJune302014UnauditedConsolidatedFinancialStatements">
<link:definition> 121 - Disclosure - Restatement of June 30, 2014 Unaudited Consolidated Financial Statements </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/SubsequentEvents" id="SubsequentEvents">
<link:definition> 122 - Disclosure - Subsequent Events </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
<link:definition> 123 - Disclosure - Summary of Significant Accounting Policies (Policies) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/ConcentrationsTables" id="ConcentrationsTables">
<link:definition> 124 - Disclosure - Concentrations (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/CompositionOfCertainFinancialStatementCaptionsTables" id="CompositionOfCertainFinancialStatementCaptionsTables">
<link:definition> 125 - Disclosure - Composition of Certain Financial Statement Captions (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/FinancialInstrumentsTables" id="FinancialInstrumentsTables">
<link:definition> 126 - Disclosure - Financial Instruments (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/DebtTables" id="DebtTables">
<link:definition> 127 - Disclosure - Debt (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/DerivativeLiabilitiesTables" id="DerivativeLiabilitiesTables">
<link:definition> 128 - Disclosure - Derivative Liabilities (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/StockholdersEquityTables" id="StockholdersEquityTables">
<link:definition> 129 - Disclosure - Stockholders' Equity (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/CommittmentsContingenciesAndOtherMattersTables" id="CommittmentsContingenciesAndOtherMattersTables">
<link:definition> 130 - Disclosure - Committments, Contingencies and Other Matters (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/BiozoneAcquisitionTables" id="BiozoneAcquisitionTables">
<link:definition> 131 - Disclosure - Biozone Acquisition (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/IntangibleAssetsTables" id="IntangibleAssetsTables">
<link:definition> 132 - Disclosure - Intangible Assets (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/RestatementOfJune302014UnauditedConsolidatedFinancialStatementsTables" id="RestatementOfJune302014UnauditedConsolidatedFinancialStatementsTables">
<link:definition> 133 - Disclosure - Restatement of June 30, 2014 Unaudited Consolidated Financial Statements (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/CompositionOfCertainFinancialStatementCaptionsDetails" id="CompositionOfCertainFinancialStatementCaptionsDetails">
<link:definition> 134 - Disclosure - Composition of Certain Financial Statement Captions (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/CompositionOfCertainFinancialStatementCaptionsDetails1" id="CompositionOfCertainFinancialStatementCaptionsDetails1">
<link:definition> 135 - Disclosure - Composition of Certain Financial Statement Captions (Details 1) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/CompositionOfCertainFinancialStatementCaptionsDetails2" id="CompositionOfCertainFinancialStatementCaptionsDetails2">
<link:definition> 136 - Disclosure - Composition of Certain Financial Statement Captions (Details 2) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/CompositionOfCertainFinancialStatementCaptionsDetails3" id="CompositionOfCertainFinancialStatementCaptionsDetails3">
<link:definition> 137 - Disclosure - Composition of Certain Financial Statement Captions (Details 3) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/CompositionOfCertainFinancialStatementCaptionsDetails5" id="CompositionOfCertainFinancialStatementCaptionsDetails5">
<link:definition> 138 - Disclosure - Composition of Certain Financial Statement Captions (Details 5) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/CompositionOfCertainFinancialStatementCaptionsDetails4" id="CompositionOfCertainFinancialStatementCaptionsDetails4">
<link:definition> 139 - Disclosure - Composition of Certain Financial Statement Captions (Details 4) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/CompositionOfCertainFinancialStatementCaptionsDetails6" id="CompositionOfCertainFinancialStatementCaptionsDetails6">
<link:definition> 140 - Disclosure - Composition of Certain Financial Statement Captions (Details 6) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/CompositionOfCertainFinancialStatementCaptionsDetails7" id="CompositionOfCertainFinancialStatementCaptionsDetails7">
<link:definition> 141 - Disclosure - Composition of Certain Financial Statement Captions (Details 7) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/CompositionOfCertainFinancialStatementCaptionsDetails8" id="CompositionOfCertainFinancialStatementCaptionsDetails8">
<link:definition> 142 - Disclosure - Composition of Certain Financial Statement Captions (Details 8) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/CompositionOfCertainFinancialStatementCaptionsDetailsTextual" id="CompositionOfCertainFinancialStatementCaptionsDetailsTextual">
<link:definition> 143 - Disclosure - Composition of Certain Financial Statement Captions (Details Textual) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/ConcentrationsDetails" id="ConcentrationsDetails">
<link:definition> 144 - Disclosure - Concentrations (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/ConcentrationsDetails1" id="ConcentrationsDetails1">
<link:definition> 145 - Disclosure - Concentrations (Details 1) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/ConcentrationsDetails2" id="ConcentrationsDetails2">
<link:definition> 146 - Disclosure - Concentrations (Details 2) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/FinancialInstrumentsDetails" id="FinancialInstrumentsDetails">
<link:definition> 147 - Disclosure - Financial Instruments (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/FinancialInstrumentsDetailsTextual" id="FinancialInstrumentsDetailsTextual">
<link:definition> 148 - Disclosure - Financial Instruments (Details Textual) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/DebtDetails" id="DebtDetails">
<link:definition> 149 - Disclosure - Debt (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/DebtDetails1" id="DebtDetails1">
<link:definition> 150 - Disclosure - Debt (Details 1) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/DebtDetails2" id="DebtDetails2">
<link:definition> 151 - Disclosure - Debt (Details 2) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/DebtDetailsTextual" id="DebtDetailsTextual">
<link:definition> 152 - Disclosure - Debt (Details Textual) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/DerivativeLiabilitiesDetails" id="DerivativeLiabilitiesDetails">
<link:definition> 153 - Disclosure - Derivative Liabilities (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/DerivativeLiabilitiesDetailsTextual" id="DerivativeLiabilitiesDetailsTextual">
<link:definition> 154 - Disclosure - Derivative Liabilities (Details Textual) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/RestrictedStockUnitsDetailsTextual" id="RestrictedStockUnitsDetailsTextual">
<link:definition> 155 - Disclosure - Restricted Stock Units (Details Textual) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/StockholdersEquityDetails" id="StockholdersEquityDetails">
<link:definition> 156 - Disclosure - Stockholders' Equity (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/StockholdersEquityDetails1" id="StockholdersEquityDetails1">
<link:definition> 157 - Disclosure - Stockholders' Equity (Details 1) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/StockholdersEquityDetails2" id="StockholdersEquityDetails2">
<link:definition> 158 - Disclosure - Stockholders' Equity (Details 2) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/StockholdersEquityDetails3" id="StockholdersEquityDetails3">
<link:definition> 159 - Disclosure - Stockholders' Equity (Details 3) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/StockholdersEquityDetailsTextual" id="StockholdersEquityDetailsTextual">
<link:definition> 160 - Disclosure - Stockholders' Equity (Details Textual) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/CommitmentsContingenciesAndOtherMattersDetails" id="CommitmentsContingenciesAndOtherMattersDetails">
<link:definition> 161 - Disclosure - Commitments, Contingencies and Other Matters (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/CommitmentsContingenciesAndOtherMattersDetails1" id="CommitmentsContingenciesAndOtherMattersDetails1">
<link:definition> 162 - Disclosure - Commitments, Contingencies and Other Matters (Details 1) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/CommitmentsContingenciesAndOtherMattersDetails2" id="CommitmentsContingenciesAndOtherMattersDetails2">
<link:definition> 163 - Disclosure - Commitments, Contingencies and Other Matters (Details 2) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/CommitmentsContingenciesAndOtherMattersDetailsTextual" id="CommitmentsContingenciesAndOtherMattersDetailsTextual">
<link:definition> 164 - Disclosure - Commitments, Contingencies and Other Matters (Details Textual) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/DefinedContributionPlanDetailsTextual" id="DefinedContributionPlanDetailsTextual">
<link:definition> 165 - Disclosure - Defined Contribution Plan (Details Textual) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/RelatedPartyTransactionsDetailsTextual" id="RelatedPartyTransactionsDetailsTextual">
<link:definition> 166 - Disclosure - Related Party Transactions (Details Textual) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/EndorsementAgreementDetailsTextual" id="EndorsementAgreementDetailsTextual">
<link:definition> 167 - Disclosure - Endorsement Agreement (Details Textual) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/BiozoneAcquisitionDetails" id="BiozoneAcquisitionDetails">
<link:definition> 168 - Disclosure - Biozone Acquisition (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/BiozoneAcquisitionDetails1" id="BiozoneAcquisitionDetails1">
<link:definition> 169 - Disclosure - Biozone Acquisition (Details 1) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/BiozoneAcquisitionDetails2" id="BiozoneAcquisitionDetails2">
<link:definition> 170 - Disclosure - Biozone Acquisition (Details 2) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/BiozoneAcquisitionDetailsTextual" id="BiozoneAcquisitionDetailsTextual">
<link:definition> 171 - Disclosure - Biozone Acquisition (Details Textual) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/IntangibleAssetsDetails" id="IntangibleAssetsDetails">
<link:definition> 172 - Disclosure - Intangible Assets (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/IntangibleAssetsDetails1" id="IntangibleAssetsDetails1">
<link:definition> 173 - Disclosure - Intangible Assets (Details 1) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/IntangibleAssetsDetailsTextual" id="IntangibleAssetsDetailsTextual">
<link:definition> 174 - Disclosure - Intangible Assets (Details Textual) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/RestatementOfJune302014UnauditedConsolidatedFinancialStatementsDetails" id="RestatementOfJune302014UnauditedConsolidatedFinancialStatementsDetails">
<link:definition> 175 - Disclosure - Restatement of June 30, 2014 Unaudited Consolidated Financial Statements (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/RestatementOfJune302014UnauditedConsolidatedFinancialStatementsDetailsTextual" id="RestatementOfJune302014UnauditedConsolidatedFinancialStatementsDetailsTextual">
<link:definition> 176 - Disclosure - Restatement of June 30, 2014 Unaudited Consolidated Financial Statements (Details Textual) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.musclepharm.com/role/SubsequentEventsDetailsTextual" id="SubsequentEventsDetailsTextual">
<link:definition> 177 - Disclosure - Subsequent Events (Details Textual) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
</link:roleType>
<link:linkbaseRef xlink:type="simple" xlink:href="mslp-20140630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="mslp-20140630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="mslp-20140630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="mslp-20140630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
</appinfo>
</annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
<import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<import namespace="http://fasb.org/us-gaap/2014-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/country/2013-01-31" schemaLocation="http://xbrl.sec.gov/country/2013/country-2013-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/currency/2014-01-31" schemaLocation="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/exch/2014-01-31" schemaLocation="http://xbrl.sec.gov/exch/2014/exch-2014-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/naics/2011-01-31" schemaLocation="http://xbrl.sec.gov/naics/2011/naics-2011-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/stpr/2011-01-31" schemaLocation="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd"/>
<import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"/>
<import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd"/>
<import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd"/>
<import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
<import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
<import namespace="http://fasb.org/us-types/2014-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2014/elts/us-types-2014-01-31.xsd"/>
<element name="ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsAbstract"/>
<element name="ScheduleOfShareBasedCompensationRestrictedStockUnitsTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_ScheduleOfShareBasedCompensationRestrictedStockUnitsTextBlock"/>
<element name="SeriesConvertiblePreferredStockMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_SeriesConvertiblePreferredStockMember"/>
<element name="SeriesCConvertiblePreferredStockMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_SeriesCConvertiblePreferredStockMember"/>
<element name="SeriesDConvertiblePreferredStockMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_SeriesDConvertiblePreferredStockMember"/>
<element name="PrepaidExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" xbrli:balance="debit" substitutionGroup="xbrli:item" id="mslp_PrepaidExpenses"/>
<element name="PrepaidStockCompensationCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" xbrli:balance="debit" substitutionGroup="xbrli:item" id="mslp_PrepaidStockCompensationCurrent"/>
<element name="PrepaidSponsorshipAndEndorsementFeesCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" xbrli:balance="debit" substitutionGroup="xbrli:item" id="mslp_PrepaidSponsorshipAndEndorsementFeesCurrent"/>
<element name="PrepaidStockCompensationNonCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" xbrli:balance="debit" substitutionGroup="xbrli:item" id="mslp_PrepaidStockCompensationNonCurrent"/>
<element name="EndorsementAgreementAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_EndorsementAgreementAbstract"/>
<element name="EndorsementAgreementTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_EndorsementAgreementTextBlock"/>
<element name="RisksAndUncertaintiesPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_RisksAndUncertaintiesPolicyTextBlock"/>
<element name="AccountsReceivableAndAllowanceForDoubtfulAccountsPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_AccountsReceivableAndAllowanceForDoubtfulAccountsPolicyTextBlock"/>
<element name="PrepaidGivewaysPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_PrepaidGivewaysPolicyTextBlock"/>
<element name="PrepaidSponsorshipFeesPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_PrepaidSponsorshipFeesPolicyTextBlock"/>
<element name="PrepaidExpensesPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_PrepaidExpensesPolicyTextBlock"/>
<element name="AccruedLiabilitiesPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_AccruedLiabilitiesPolicyTextBlock"/>
<element name="ConsolidatedBalanceSheetsParentheticalAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_ConsolidatedBalanceSheetsParentheticalAbstract"/>
<element name="ScheduleOfLongTermDebtTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_ScheduleOfLongTermDebtTableTextBlock"/>
<element name="ScheduleOfConvertibleDebtActivityAndTermsTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_ScheduleOfConvertibleDebtActivityAndTermsTableTextBlock"/>
<element name="ScheduleOfAutoLoanActivityAndTermsTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_ScheduleOfAutoLoanActivityAndTermsTableTextBlock"/>
<element name="ScheduleOfFairValueOfDerivativeInstrumentsConversionFeatureTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_ScheduleOfFairValueOfDerivativeInstrumentsConversionFeatureTableTextBlock"/>
<element name="ScheduleOfCommonStockEquivalentsTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_ScheduleOfCommonStockEquivalentsTableTextBlock"/>
<element name="SponsorshipAndEndorsementContractLiabilitiesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_SponsorshipAndEndorsementContractLiabilitiesMember"/>
<element name="ScheduleOfBusinessCombinationAcquiredReceivablesTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_ScheduleOfBusinessCombinationAcquiredReceivablesTableTextBlock"/>
<element name="ProfessionalFeesResearchAndDevelopmentExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="debit" substitutionGroup="xbrli:item" id="mslp_ProfessionalFeesResearchAndDevelopmentExpense"/>
<element name="CompositionOfCertainFinancialStatementCaptionsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mslp_CompositionOfCertainFinancialStatementCaptionsTable"/>
<element name="CompositionOfCertainFinancialStatementCaptionsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_CompositionOfCertainFinancialStatementCaptionsLineItems"/>
<element name="AllowanceForDiscounts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="mslp_AllowanceForDiscounts"/>
<element name="CompositionOfCertainFinancialStatementCaptionsTableAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_CompositionOfCertainFinancialStatementCaptionsTableAbstract"/>
<element name="WarrantsOneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_WarrantsOneMember"/>
<element name="EmployeeAndDirectorUnvestedSharesMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_EmployeeAndDirectorUnvestedSharesMember"/>
<element name="ConvertiblePreferredStockSeriesCMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_ConvertiblePreferredStockSeriesCMember"/>
<element name="CommonStockEquivalentsShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_CommonStockEquivalentsShares"/>
<element name="ConversionOfSeriesCPreferredStockMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_ConversionOfSeriesCPreferredStockMember"/>
<element name="AmortizationOfPrepaidSponsorshipFees" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="debit" substitutionGroup="xbrli:item" id="mslp_AmortizationOfPrepaidSponsorshipFees"/>
<element name="AmortizationOfConversionOption" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="debit" substitutionGroup="xbrli:item" id="mslp_AmortizationOfConversionOption"/>
<element name="GainLossOnConversionOfSecurities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="mslp_GainLossOnConversionOfSecurities"/>
<element name="IncreaseDecreaseInPrepaidAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="mslp_IncreaseDecreaseInPrepaidAssets"/>
<element name="ProceedsFromIssuanceOfCommonStockAndWarrantsNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="debit" substitutionGroup="xbrli:item" id="mslp_ProceedsFromIssuanceOfCommonStockAndWarrantsNet"/>
<element name="CashFlowsFromEquityActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_CashFlowsFromEquityActivitiesAbstract"/>
<element name="StockIssuedForFutureServicesThirdParties" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="mslp_StockIssuedForFutureServicesThirdParties"/>
<element name="WarrantsIssuedInConjunctionWithEquityIssuances" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="debit" substitutionGroup="xbrli:item" id="mslp_WarrantsIssuedInConjunctionWithEquityIssuances"/>
<element name="StockIssuedToSettleAccountsPayableAndAccruedinterest" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="debit" substitutionGroup="xbrli:item" id="mslp_StockIssuedToSettleAccountsPayableAndAccruedinterest"/>
<element name="StockIssuedForExecutiveAndBoardCompensation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="mslp_StockIssuedForExecutiveAndBoardCompensation"/>
<element name="ManufacturingAndLabEquipmentMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_ManufacturingAndLabEquipmentMember"/>
<element name="DisplaysMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_DisplaysMember"/>
<element name="WebsiteMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_WebsiteMember"/>
<element name="ThirdPartyManufacturersMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_ThirdPartyManufacturersMember"/>
<element name="AutoLoanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_AutoLoanMember"/>
<element name="VehicleLoanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_VehicleLoanMember"/>
<element name="UsBankNaDSavingsDepositsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_UsBankNaDSavingsDepositsMember"/>
<element name="ScheduleOfDerivativeLiabiltiesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mslp_ScheduleOfDerivativeLiabiltiesTable"/>
<element name="DerivativeLiabiltiesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_DerivativeLiabiltiesLineItems"/>
<element name="FairValueMarkToMarketAdjustmentForEquityInstruments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="mslp_FairValueMarkToMarketAdjustmentForEquityInstruments"/>
<element name="ReclassificationOfDerivativeLiabilitiesToAdditionalPaidInCapital" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="debit" substitutionGroup="xbrli:item" id="mslp_ReclassificationOfDerivativeLiabilitiesToAdditionalPaidInCapital"/>
<element name="KeyEmployeesOfficersAndDirectorsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_KeyEmployeesOfficersAndDirectorsMember"/>
<element name="December312013Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_December312013Member"/>
<element name="December312015Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_December312015Member"/>
<element name="SharesVestingInNextTwelveMonthsNumber" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mslp_SharesVestingInNextTwelveMonthsNumber"/>
<element name="SharesVestingInYearTwoNumber" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mslp_SharesVestingInYearTwoNumber"/>
<element name="RestrictedStockAgreementGrantVestingPercentage" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_RestrictedStockAgreementGrantVestingPercentage"/>
<element name="ConversionPriceOfPeferredStock" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_ConversionPriceOfPeferredStock"/>
<element name="StockIssuedDuringPeriodPricePerShareShareBasedCompensation" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_StockIssuedDuringPeriodPricePerShareShareBasedCompensation"/>
<element name="StockIssuedDuringPeriodValuePerSharePurchaseOfAssets" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_StockIssuedDuringPeriodValuePerSharePurchaseOfAssets"/>
<element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod"/>
<element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePricePerShare" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mslp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePricePerShare"/>
<element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePricePerShare" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePricePerShare"/>
<element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePricePerShare" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePricePerShare"/>
<element name="WarrantOutstandingNumberOutstanding" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_WarrantOutstandingNumberOutstanding"/>
<element name="WarrantOutstandingWeightedAverageExercisePrice" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mslp_WarrantOutstandingWeightedAverageExercisePrice"/>
<element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mslp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber"/>
<element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableExercisePricePerShare" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mslp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableExercisePricePerShare"/>
<element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableIntrinsicValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="mslp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableIntrinsicValue"/>
<element name="StockholdersEquityDisclosureTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mslp_StockholdersEquityDisclosureTable"/>
<element name="ConversionOfPreferredStockToCommonStockMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_ConversionOfPreferredStockToCommonStockMember"/>
<element name="FairValueAtDateAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem" id="mslp_FairValueAtDateAxis"/>
<element name="FairValueAtDateDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_FairValueAtDateDomain"/>
<element name="CommitmentDateMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_CommitmentDateMember"/>
<element name="ReMeasurementDateMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_ReMeasurementDateMember"/>
<element name="WarrantOneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_WarrantOneMember"/>
<element name="SettlementOfAccountsPayableAndLossOnSettlementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_SettlementOfAccountsPayableAndLossOnSettlementMember"/>
<element name="SettlementOfNotesPayableMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_SettlementOfNotesPayableMember"/>
<element name="Plan2010Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_Plan2010Member"/>
<element name="GrqMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_GrqMember"/>
<element name="MelechdavidMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_MelechdavidMember"/>
<element name="AmendedAgreementAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem" id="mslp_AmendedAgreementAxis"/>
<element name="AmendedAgreementDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_AmendedAgreementDomain"/>
<element name="GrqAmendedAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_GrqAmendedAgreementMember"/>
<element name="StockRepurchasePlanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_StockRepurchasePlanMember"/>
<element name="StockholdersEquityDisclosureLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_StockholdersEquityDisclosureLineItems"/>
<element name="NumberOfSharesSoldUnderSubscriptionAgreement" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_NumberOfSharesSoldUnderSubscriptionAgreement"/>
<element name="ContractualObligationFiscalYearMaturityTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mslp_ContractualObligationFiscalYearMaturityTable"/>
<element name="EndorsementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_EndorsementMember"/>
<element name="SponsorshipMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_SponsorshipMember"/>
<element name="ServiceMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_ServiceMember"/>
<element name="ContractualObligationFiscalYearMaturityLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_ContractualObligationFiscalYearMaturityLineItems"/>
<element name="CommitmentsAndContingencyTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mslp_CommitmentsAndContingencyTable"/>
<element name="FactoringAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_FactoringAgreementMember"/>
<element name="LegalMattersMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_LegalMattersMember"/>
<element name="SettlementOfDisputeMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_SettlementOfDisputeMember"/>
<element name="OutstandingAccountsPayableMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_OutstandingAccountsPayableMember"/>
<element name="WilliamBossungAndBishopEquityPartnersLlcMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_WilliamBossungAndBishopEquityPartnersLlcMember"/>
<element name="BiozoneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_BiozoneMember"/>
<element name="CommitmentsAndContingencyLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_CommitmentsAndContingencyLineItems"/>
<element name="OperatingLeaseExpireTerm" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_OperatingLeaseExpireTerm"/>
<element name="ProductLiabilityInsuranceDeduction" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="mslp_ProductLiabilityInsuranceDeduction"/>
<element name="AggregateProductLiabilityRetainedLoss" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="debit" substitutionGroup="xbrli:item" id="mslp_AggregateProductLiabilityRetainedLoss"/>
<element name="DefinedContributionPensionAndOtherPostretirementPlansDisclosureTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mslp_DefinedContributionPensionAndOtherPostretirementPlansDisclosureTable"/>
<element name="DefinedContributionPensionAndOtherPostretirementPlansDisclosureLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_DefinedContributionPensionAndOtherPostretirementPlansDisclosureLineItems"/>
<element name="BodybuildingcomMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_BodybuildingcomMember"/>
<element name="FrostRealEstateHoldingsLlcMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_FrostRealEstateHoldingsLlcMember"/>
<element name="VpAndGeneralManagerMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_VpAndGeneralManagerMember"/>
<element name="MrCiccarelliMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_MrCiccarelliMember"/>
<element name="SecuritiesPurchaseUnderAgreementDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_SecuritiesPurchaseUnderAgreementDescription"/>
<element name="EndorsementAgreementDisclosureTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mslp_EndorsementAgreementDisclosureTable"/>
<element name="ArnoldProductLineMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_ArnoldProductLineMember"/>
<element name="AgreementAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem" id="mslp_AgreementAxis"/>
<element name="AgreementDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_AgreementDomain"/>
<element name="EndorsementLicensingAndCobrandingAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_EndorsementLicensingAndCobrandingAgreementMember"/>
<element name="MarineMpLlcMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_MarineMpLlcMember"/>
<element name="EndorsementAgreementDisclosureLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_EndorsementAgreementDisclosureLineItems"/>
<element name="NetTangibleAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_NetTangibleAssetsAbstract"/>
<element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesFactoringPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="mslp_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesFactoringPayable"/>
<element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentLeasesLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="mslp_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentLeasesLiabilities"/>
<element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEmployeeVacationLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="mslp_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEmployeeVacationLiability"/>
<element name="FactoringReceivableMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_FactoringReceivableMember"/>
<element name="AssetSaleReceivableMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_AssetSaleReceivableMember"/>
<element name="BusinessAcquisitionProFormaNetLossPerCommonShareAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_BusinessAcquisitionProFormaNetLossPerCommonShareAbstract"/>
<element name="EscrowMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_EscrowMember"/>
<element name="NonescrowedMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_NonescrowedMember"/>
<element name="EscrowPeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_EscrowPeriod"/>
<element name="IntangibleAssetsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mslp_IntangibleAssetsTable"/>
<element name="IntangibleAssetsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_IntangibleAssetsLineItems"/>
<element name="FinitelivedIntangibleAssetsNetAmortizationExpenseFiscalYearMaturityTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mslp_FinitelivedIntangibleAssetsNetAmortizationExpenseFiscalYearMaturityTable"/>
<element name="FinitelivedIntangibleAssetsNetAmortizationExpenseFiscalYearMaturityLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_FinitelivedIntangibleAssetsNetAmortizationExpenseFiscalYearMaturityLineItems"/>
<element name="FiniteLivedIntangibleAssetsAmortizationExpense1" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" xbrli:balance="debit" substitutionGroup="xbrli:item" id="mslp_FiniteLivedIntangibleAssetsAmortizationExpense1"/>
<element name="BiozoneLaboratoriesLtdMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_BiozoneLaboratoriesLtdMember"/>
<element name="FuseScienceIncMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_FuseScienceIncMember"/>
<element name="JohnHBluherMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_JohnHBluherMember"/>
<element name="SeniorSecuredConvertiblePromissoryNoteMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_SeniorSecuredConvertiblePromissoryNoteMember"/>
<element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_DocumentAndEntityInformationAbstract"/>
<element name="FinancialInstrumentsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mslp_FinancialInstrumentsTable"/>
<element name="FinancialInstrumentsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_FinancialInstrumentsLineItems"/>
<element name="SaleOfConvertibleNotesAndWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="mslp_SaleOfConvertibleNotesAndWarrants"/>
<element name="CustomerMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_CustomerMember"/>
<element name="CustomerBMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_CustomerBMember"/>
<element name="CustomerCMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_CustomerCMember"/>
<element name="VendorMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_VendorMember"/>
<element name="VendorBMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_VendorBMember"/>
<element name="CompositionOfCertainFinancialStatementCaptionsAbstractAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_CompositionOfCertainFinancialStatementCaptionsAbstractAbstract"/>
<element name="CompositionOfCertainFinancialStatementCaptionsTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_CompositionOfCertainFinancialStatementCaptionsTextBlock"/>
<element name="ScheduleOfAccountsReceivableTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_ScheduleOfAccountsReceivableTableTextBlock"/>
<element name="ScheduleOfPrepaidExpenseCurrentTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_ScheduleOfPrepaidExpenseCurrentTableTextBlock"/>
<element name="ScheduleOfSalesTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_ScheduleOfSalesTableTextBlock"/>
<element name="BiozonePharmaceuticalsIncMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_BiozonePharmaceuticalsIncMember"/>
<element name="BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted"/>
<element name="BusinessAcquisitionProformaWeightedAverageNumberOfCommonSharesBasicAndDiluted" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_BusinessAcquisitionProformaWeightedAverageNumberOfCommonSharesBasicAndDiluted"/>
<element name="PrepaidProfessionalServices" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" xbrli:balance="debit" substitutionGroup="xbrli:item" id="mslp_PrepaidProfessionalServices"/>
<element name="PrepaidDirectorFees" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" xbrli:balance="debit" substitutionGroup="xbrli:item" id="mslp_PrepaidDirectorFees"/>
<element name="PrepaidResearchAndDevelopmentFees" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" xbrli:balance="debit" substitutionGroup="xbrli:item" id="mslp_PrepaidResearchAndDevelopmentFees"/>
<element name="PrepaidSoftwareLicenseFees" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" xbrli:balance="debit" substitutionGroup="xbrli:item" id="mslp_PrepaidSoftwareLicenseFees"/>
<element name="PrepaidSupportAgreements" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" xbrli:balance="debit" substitutionGroup="xbrli:item" id="mslp_PrepaidSupportAgreements"/>
<element name="CombinedBeforeProFormaAdjustmentsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_CombinedBeforeProFormaAdjustmentsMember"/>
<element name="ProFormaAdjustmentsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_ProFormaAdjustmentsMember"/>
<element name="VendorRebateReceivableCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" xbrli:balance="debit" substitutionGroup="xbrli:item" id="mslp_VendorRebateReceivableCurrent"/>
<element name="OtherReceivableCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" xbrli:balance="debit" substitutionGroup="xbrli:item" id="mslp_OtherReceivableCurrent"/>
<element name="PrepaidAssetsNoncurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" xbrli:balance="debit" substitutionGroup="xbrli:item" id="mslp_PrepaidAssetsNoncurrent"/>
<element name="AccruedPayablesCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="mslp_AccruedPayablesCurrent"/>
<element name="SalesDiscountsReturnsAndAllowancesGoodsPercentageOnGrossSales" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_SalesDiscountsReturnsAndAllowancesGoodsPercentageOnGrossSales"/>
<element name="StockIssuedDuringPeriodSharesTotal" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_StockIssuedDuringPeriodSharesTotal"/>
<element name="StockIssuedDuringPeriodValueTotal" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="mslp_StockIssuedDuringPeriodValueTotal"/>
<element name="StockIssuedDuringPeriodPricePerShareTotal" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_StockIssuedDuringPeriodPricePerShareTotal"/>
<element name="ScheduleOfWarrantsActivityTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_ScheduleOfWarrantsActivityTableTextBlock"/>
<element name="CapitalLeaseExpireTerm" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mslp_CapitalLeaseExpireTerm"/>
</schema>

↑Top
Filing Submission 0001144204-14-064325   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sat., Apr. 27, 3:25:21.1am ET